Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis

被引:3
|
作者
Wong, Karen H. Y. [1 ]
Levy-Sakin, Michal [1 ]
Ma, Waifred [1 ]
Gonzaludo, Nina [1 ]
Mak, Angel C. Y. [1 ,2 ]
Vaka, Dedeem A. [3 ]
Poon, Annie [3 ]
Chu, Catherine [3 ]
Lao, Richard [3 ]
Balamir, Melek [4 ]
Grenville, Zoe [1 ]
Wong, Nicolas [1 ]
Kane, John P. [1 ,5 ,6 ]
Kwok, Pui-Yan [1 ,3 ,7 ]
Malloy, Mary J. [1 ,5 ,8 ]
Pullinger, Clive R. [1 ,9 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA
[4] Istanbul Univ, Dept Internal Med, Istanbul, Turkey
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[9] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 12期
基金
美国国家卫生研究院;
关键词
10xG linked-reads whole genome sequencing; dyslipidemia; LDL; whole exome sequencing; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL RECEPTOR GENE; MUTATIONS; IDENTIFICATION; POPULATION; PREVALENCE; VARIANTS; PLASMA; INDIVIDUALS; DISEASE;
D O I
10.1002/mgg3.1007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Homozygous Familial Hypercholesterolemia (HoFH) is an inherited recessive condition associated with extremely high levels of low-density lipoprotein (LDL) cholesterol in affected individuals. It is usually caused by homozygous or compound heterozygous functional mutations in the LDL receptor (LDLR). A number of mutations causing FH have been reported in literature and such genetic heterogeneity presents great challenges for disease diagnosis. Objective We aim to determine the likely genetic defects responsible for three cases of pediatric HoFH in two kindreds. Methods We applied whole exome sequencing (WES) on the two probands to determine the likely functional variants among candidate FH genes. We additionally applied 10x Genomics (10xG) Linked-Reads whole genome sequencing (WGS) on one of the kindreds to identify potentially deleterious structural variants (SVs) underlying HoFH. A PCR-based screening assay was also established to detect the LDLR structural variant in a cohort of 641 patients with elevated LDL. Results In the Caucasian kindred, the FH homozygosity can be attributed to two compound heterozygous LDLR damaging variants, an exon 12 p.G592E missense mutation and a novel 3kb exon 1 deletion. By analyzing the 10xG phased data, we ascertained that this deletion allele was most likely to have originated from a Russian ancestor. In the Mexican kindred, the strikingly elevated LDL cholesterol level can be attributed to a homozygous frameshift LDLR variant p.E113fs. Conclusions While the application of WES can provide a cost-effective way of identifying the genetic causes of FH, it often lacks sensitivity for detecting structural variants. Our finding of the LDLR exon 1 deletion highlights the broader utility of Linked-Read WGS in detecting SVs in the clinical setting, especially when HoFH patients remain undiagnosed after WES.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Lomitapide for the Management of Homozygous Familial Hypercholesterolemia
    deGoma, Emil M.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (02) : 109 - 118
  • [32] Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High-Dose Statin Therapy
    Raal, Frederick
    Panz, Vanessa
    Immelman, Andrew
    Pilcher, Gillian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02):
  • [33] Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia
    Huang, Chin-Chou
    Niu, Dau-Ming
    Charng, Min-Ji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (05) : 639 - 653
  • [34] Recommendations for the Management of Patients with Familial Hypercholesterolemia
    Feldman, David I.
    Blaha, Michael J.
    Santos, Raul D.
    Jones, Steve R.
    Blumenthal, Roger S.
    Toth, Peter P.
    Sperling, Laurence S.
    Martin, Seth S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (01)
  • [35] The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study
    Luirink, Ilse K.
    Braamskamp, Marjet J. A. M.
    Wiegman, Albert
    Hartgers, Merel L.
    Sjouke, Barbara
    Defesche, Joep C.
    Hovingh, G. Kees
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (02) : 272 - 278
  • [36] Gene expression analysis of familial hypercholesterolemia
    Jiang, J.
    Chen, H.
    Wang, L.
    MOLECULAR BIOLOGY, 2014, 48 (01) : 158 - 164
  • [37] Genetic Characteristics of Latvian Patients with Familial Hypercholesterolemia: The First Analysis from Genome-Wide Sequencing
    Latkovskis, Gustavs
    Rescenko-Krums, Raimonds
    Nesterovics, Georgijs
    Briviba, Monta
    Saripo, Vita
    Gilis, Dainus
    Terauda, Elizabete
    Meiere, Ruta
    Skudrina, Gunda
    Erglis, Andrejs
    Chora, Joana Rita
    Bourbon, Mafalda
    Klovins, Janis
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [38] Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Izar, Maria C.
    Machado, Valeria A.
    Fonseca, Francisco A.
    APPLICATION OF CLINICAL GENETICS, 2010, 3 : 147 - 157
  • [39] Homozygous familial hypercholesterolemia and its treatment by inclisiran
    Marais, A. David
    Blom, Dirk J.
    Raal, Frederick J.
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (06): : 197 - 207
  • [40] High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Lamarche, Benoit
    Couture, Patrick
    ATHEROSCLEROSIS, 2018, 270 : 26 - 32